Benzinga | Nov 5, 2021 12:00PM EDT

Roth Capital Downgrades CryoPort to Neutral, Raises Price Target to $90

Roth Capital analyst Richard Baldry downgrades CryoPort (NASDAQ:CYRX) from Buy to Neutral and raises the price target from $78 to $90.